Pathophysiology of ANCA-associated vasculitis: Are ANCA really pathogenic? A note of caution To the Editor: In their recent article, Heeringa and Cohen Tervaert summarized the evidences for the widely accepted conception, that antineutrophil-cytoplasmic autoauntibodies (ANCA), by activating neutrophils, are the "major players" in the pathogenesis of small vessel vasculitis [1] . We feel a note of caution is appropriate.
First, there is no evidence for binding of ANCA to polymorphonuclear neutrophils (PMN) (or monocytes) in vivo: in patients with high ANCA titer, immunoglobulin G (IgG) deposits cannot be detected on PMN, although the target antigen, for example, PR3, could be detected by use of a heterologous antibody (e.g., in the histologic study described in [2] , or the the ex vivo analysis of peripheral blood PMN described in [3] ).
Second, to the best of our knowledge, the experiments using ANCA for activation of PMN in vitro were perfomed with purified IgG, or with heterologous antibodies, respectively. According to our experience, the affinity of the ANCA for PMN is far too low for binding in the presence of other plasma proteins. With purified IgG, the low affinity binding can be overcome by high input of purified protein. Thus, stimulation of PMN by ANCA may not occur under in vivo conditions. Third, in the studies with experimental animals (as reported, e.g., in [4] ), the antibodies generated against myeloperoxidase (MPO) are not true autoantibodies, because animals deficient for MPO were used for immunization. These animals are not tolerant to MPO, and consequently, lymphocytes with high reactivity towards "self-MPO" will not be eliminated, leading to the generation of antibodies with high affinity binding. In contrast, when self-tolerance is operative (as it is in humans), antibodies with low affinity binding are produced, which will greatly differ with regard to their interaction with potential target antigens.
While these argument do not necessarily rule out a role of ANCA in vasculitis-or of the PMN-they challenge the current model of ANCA-mediated PMN activation as a major pathogenic factor. GERTRUD 
